Amarantus BioScience Holdings, Inc. (NASDAQ: AMBS) is a biotechnology company developing treatments and diagnostics for diseases associated with endoplasmic reticulum stress, cell cycle dysregulation, neurodegeneration and apoptosis (programmed cell death). In addition to owning intellectual property for the diagnosis of Parkinson’s disease (“NuroPro”) and the discovery of neurotrophic factors (“PhenoGuard”), the company is also a founding member of the Coalition for Concussion Treatment, which raises awareness for concussions and nervous-system disorders. For more information, visit the company’s website at www.amarantus.com.

Noble Financial Capital Markets, an equity research driven, full-service, investment banking boutique, is hosting its tenth annual equity conference in Sandpiper Bay, FL. Attended by institutional investors from across North America, the event features more than 140 public company executive teams from a diverse range of industries. For more information, visit www.noble.missionir.com.